Holen Sie sich die Stockscreener-App
23.38
0.13%
0.03
Handel nachbörslich:
23.25
-0.13
-0.56%
Schlusskurs vom Vortag:
$23.35
Offen:
$23.35
24-Stunden-Volumen:
601.77K
Relative Volume:
0.52
Marktkapitalisierung:
$1.15B
Einnahmen:
$224.45M
Nettoeinkommen (Verlust:
$-95.27M
KGV:
-12.11
EPS:
-1.93
Netto-Cashflow:
$-43.74M
1W Leistung:
-3.39%
1M Leistung:
-11.91%
6M Leistung:
+38.18%
1J Leistung:
-3.43%
1-Tages-Spanne:
$23.30
$23.74
1-Wochen-Bereich:
$23.30
$24.28
52-Wochen-Spanne:
$13.50
$30.81
Staar Surgical Co Stock (STAA) Company Profile
Firmenname
Staar Surgical Co
Sektor
Telefon
(626) 303-7902
Adresse
1911 WALKER AVE, MONROVIA, CA
Vergleichen Sie STAA mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
STAA
Staar Surgical Co
|
23.38 | 1.15B | 224.45M | -95.27M | -43.74M | -1.93 |
|
ISRG
Intuitive Surgical Inc
|
575.40 | 204.83B | 9.61B | 2.77B | 2.27B | 7.555 |
|
BDX
Becton Dickinson Co
|
195.16 | 55.94B | 21.84B | 1.68B | 2.67B | 5.8293 |
|
ALC
Alcon Inc
|
80.35 | 39.48B | 10.19B | 1.05B | 1.38B | 2.1044 |
|
RMD
Resmed Inc
|
242.85 | 35.73B | 5.26B | 1.44B | 1.76B | 9.7713 |
|
MDLN
Medline Inc
|
42.00 | 34.74B | 27.43B | 1.27B | 1.01B | 1.5829 |
Staar Surgical Co Stock (STAA) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-04-21 | Eingeleitet | Wells Fargo | Equal Weight |
| 2025-02-12 | Herabstufung | BTIG Research | Buy → Neutral |
| 2025-02-12 | Herabstufung | Jefferies | Buy → Hold |
| 2025-02-12 | Herabstufung | Mizuho | Outperform → Neutral |
| 2025-02-12 | Herabstufung | William Blair | Outperform → Mkt Perform |
| 2024-07-15 | Herabstufung | Morgan Stanley | Equal-Weight → Underweight |
| 2024-06-11 | Hochstufung | BTIG Research | Neutral → Buy |
| 2024-03-11 | Hochstufung | Stifel | Hold → Buy |
| 2023-12-05 | Herabstufung | Needham | Buy → Hold |
| 2023-12-04 | Eingeleitet | Morgan Stanley | Equal-Weight |
| 2023-09-15 | Herabstufung | The Benchmark Company | Buy → Hold |
| 2023-08-03 | Herabstufung | Canaccord Genuity | Buy → Hold |
| 2023-06-07 | Herabstufung | William Blair | Outperform → Mkt Perform |
| 2023-04-17 | Eingeleitet | Piper Sandler | Neutral |
| 2023-02-06 | Herabstufung | BTIG Research | Buy → Neutral |
| 2022-12-28 | Bestätigt | BTIG Research | Buy |
| 2022-12-08 | Eingeleitet | Stifel | Hold |
| 2022-11-07 | Hochstufung | Sidoti | Neutral → Buy |
| 2022-10-14 | Fortgesetzt | Stephens | Overweight |
| 2022-10-13 | Eingeleitet | Mizuho | Buy |
| 2022-04-08 | Eingeleitet | Needham | Buy |
| 2022-03-28 | Hochstufung | The Benchmark Company | Hold → Buy |
| 2022-03-18 | Hochstufung | BTIG Research | Neutral → Buy |
| 2021-07-09 | Eingeleitet | Oppenheimer | Perform |
| 2021-01-19 | Herabstufung | The Benchmark Company | Buy → Hold |
| 2020-10-26 | Herabstufung | Sidoti | Buy → Neutral |
| 2020-08-31 | Hochstufung | Sidoti | Neutral → Buy |
| 2020-08-06 | Bestätigt | The Benchmark Company | Buy |
| 2020-07-06 | Herabstufung | Sidoti | Buy → Neutral |
| 2020-06-24 | Herabstufung | BTIG Research | Buy → Neutral |
| 2020-06-15 | Eingeleitet | Jefferies | Buy |
| 2019-12-04 | Eingeleitet | BTIG Research | Buy |
| 2018-09-24 | Bestätigt | The Benchmark Company | Buy |
| 2018-08-06 | Fortgesetzt | The Benchmark Company | Buy |
| 2017-11-20 | Bestätigt | The Benchmark Company | Buy |
| 2017-08-14 | Bestätigt | The Benchmark Company | Buy |
| 2017-03-03 | Bestätigt | The Benchmark Company | Buy |
| 2016-05-18 | Hochstufung | The Benchmark Company | Hold → Buy |
| 2013-09-10 | Fortgesetzt | The Benchmark Company | Buy |
| 2013-02-28 | Bestätigt | The Benchmark Company | Buy |
| 2012-11-01 | Herabstufung | Canaccord Genuity | Buy → Hold |
| 2012-03-02 | Eingeleitet | Northland Securities | Outperform |
| 2011-10-25 | Bestätigt | The Benchmark Company | Buy |
| 2010-10-12 | Eingeleitet | Morgan Joseph | Buy |
| 2010-05-11 | Eingeleitet | Benchmark | Buy |
Alle ansehen
Staar Surgical Co Aktie (STAA) Neueste Nachrichten
Midday Stock Roundup: Shimmick Corp. climbs 14% - Orange County Business Journal
What a $22 Million Bet on STAAR Surgical Signals After Third-Quarter Earnings and a 15% Market Lag - The Motley Fool
STAAR Surgical’s special meeting postponed again amid shareholder opposition By Investing.com - Investing.com Nigeria
STAAR Shareholder Vote Delayed for Fourth Time - Medical Device and Diagnostic industry
Exclusive: STAAR merger with Alcon still fails to gain traction, only 30% vote for - Investing.com Australia
STAAR Surgical’s special meeting postponed again amid shareholder opposition - Investing.com
STAAR Surgical (STAA) Rises Amid Adjourned Shareholder Vote on A - GuruFocus
Big STAAR shareholder fights yet another delay on sale to Alcon - Stock Titan
Midday Stock Roundup: Rivian Stock Continues to Climb - Orange County Business Journal
Alcon Exercises Right To Require STAAR Surgical To Adjourn Its Special Meeting Of Stockholders - TradingView — Track All Markets
Eye implant maker delays shareholder vote on merger with Alcon - Stock Titan
Will STAAR Surgical Company stock reach all time highs in 2025Trade Volume Summary & High Yield Stock Recommendations - ulpravda.ru
STAAR Surgical (NASDAQ:STAA) Shares Down 5.1%What's Next? - MarketBeat
Broadwood sees $50/share path for STAAR Surgical as merger battle nears voting day - Investing.com India
Defender Capital to vote against STAAR Surgical sale to Alcon By Investing.com - Investing.com Nigeria
Defender Capital to vote against STAAR Surgical sale to Alcon - Investing.com
STAAR Surgical (NASDAQ: STAA) faces Broadwood campaign against Alcon deal and for board shake-up - Stock Titan
STAAR urges stockholders to vote for Alcon merger amid proxy battle - Investing.com Nigeria
Broadwood urges shareholders to reject Alcon’s bid for STAAR - Investing.com
Broadwood urges Staar Surgical shareholders to vote against Alcon transaction - TipRanks
Big STAAR investor fights Alcon buyout, says shares should hit $50 - Stock Titan
STAAR Stockholders Have a Choice: Vote FOR Alcon’s Certain, Premium $30.75 Per Share Cash Offer or Bear the Downside Risk that Broadwood Has No Credible Plan to Create Stockholder Value | ALC Stock News - Stock Titan
Yunqi Capital Comments on Proxy Advisors' Updated Recommendations, Urges Shareholders to Continue to Back the Company's Standalone Trajectory - marketscreener.com
STAAR Surgical (NASDAQ: STAA) faces proxy fight over Alcon merger bid - Stock Titan
Yunqi Capital opposes Alcon deal for STAAR Surgical (NASDAQ: STAA) at $30.75 - Stock Titan
ISS recommends STAAR Surgical deal, but warns shareholders have reason to object - Investing.com
STAAR Surgical stock jumps 10% after Alcon sweetens buyout offer — investor says deal is 'worth substantially more' - MSN
Yunqi Capital to vote against revised Alcon-STAAR merger offer By Investing.com - Investing.com South Africa
Yunqi Capital to vote against revised Alcon-STAAR merger offer - Investing.com
Yunqi Capital says remains opposed to STAAR’s proposed merger with Alcon - TipRanks
Yunqi Capital Comments on Proxy Advisors’ Updated Recommendations, Urges Shareholders to Continue to Back the Company’s Standalone Trajectory - marketscreener.com
5.1% STAAR owner fights Alcon deal, arguing company is worth more - Stock Titan
STAAR Surgical (NASDAQ:STAA) Shares Gap UpTime to Buy? - MarketBeat
Alcon raises STAAR Surgical acquisition offer to $30.75 per share By Investing.com - Investing.com Nigeria
Alcon raises STAAR Surgical acquisition offer to $30.75 per share - Investing.com
Alcon (NYSE: ALC) $30.75-per-share STAAR bid gains support from analysts and ISS - Stock Titan
Proxy firms raise concerns over STAAR Surgical’s proposed sale to Alcon - Investing.com Canada
Proxy firms raise concerns over STAAR Surgical’s proposed sale to Alcon By Investing.com - Investing.com South Africa
Broadwood Partners Comments on ISS Report on Proposed Sale of STAAR Surgical to Alcon - marketscreener.com
Using the ICL as a supplementary IOL - EyeWorld
STAAR Surgical (STAA) Gains as ISS Backs Alcon's Improved Offer - GuruFocus
Opposition To The STAAR Surgical Deal Mounts – Merger Arbitrage Mondays (NASDAQ:STAA) - Seeking Alpha
Battle for STAAR Surgical intensifies as Glass Lewis reiterates stance ’against’ - Investing.com
Broadwood urges STAAR Surgical (NASDAQ: STAA) vote against Alcon sale - Stock Titan
Midday Stock Roundup: Rivian Rises on Chip, Models - Orange County Business Journal
STAAR Surgical (STAA) Faces Investor Pushback on Alcon Offer - GuruFocus
Glass Lewis Reaffirms its Recommendations to Shareholders of STAAR - marketscreener.com
Glass Lewis reaffirms opposition to Alcon’s STAAR acquisition bid - Investing.com
Glass Lewis reaffirms opposition to Alcon’s STAAR acquisition bid By Investing.com - Investing.com Australia
STAAR Surgical accuses activist Broadwood of ’misinformation campaign’ - Investing.com
[DFAN14A] STAAR SURGICAL CO SEC Filing - Stock Titan
Finanzdaten der Staar Surgical Co-Aktie (STAA)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.33%
0.01%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):